Inflammatory factors linked to inhibition of factor VIII gene therapy in hemophilia A – EurekAlert (press release)
EurekAlert (press release) |
Inflammatory factors linked to inhibition of factor VIII gene therapy in hemophilia A
EurekAlert (press release) New Rochelle, NY, December 7, 2017–As a gene therapy cure for hemophilia A moves closer to reality, a new study sheds light on a challenging complication in which a host autoimmune response inhibits the production of normal clotting factor VIII from … 1-year data set Spark/Pfizer on track with hemophilia B gene therapy Improvements to Gene Therapy Clinical Trial Design Benefit Hemophilia Patients Gene Therapy Shows Promise Against Blood-Clotting Disease |
